17.49
price down icon0.06%   -0.01
after-market Handel nachbörslich: 17.49
loading
Schlusskurs vom Vortag:
$17.50
Offen:
$16.6605
24-Stunden-Volumen:
1,137
Relative Volume:
0.05
Marktkapitalisierung:
$45.71M
Einnahmen:
$5.02M
Nettoeinkommen (Verlust:
$-18.31M
KGV:
-3.8609
EPS:
-4.53
Netto-Cashflow:
$-23.40M
1W Leistung:
+1.98%
1M Leistung:
-3.90%
6M Leistung:
+23.17%
1J Leistung:
-30.35%
1-Tages-Spanne:
Value
$16.66
$17.49
1-Wochen-Bereich:
Value
$16.40
$17.86
52-Wochen-Spanne:
Value
$12.12
$29.19

Vtv Therapeutics Inc Stock (VTVT) Company Profile

Name
Firmenname
Vtv Therapeutics Inc
Name
Telefon
336-841-0300
Name
Adresse
3980 PREMIER DR, HIGH POINT, NC
Name
Mitarbeiter
0
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
VTVT's Discussions on Twitter

Vergleichen Sie VTVT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
VTVT
Vtv Therapeutics Inc
17.49 45.71M 5.02M -18.31M -23.40M -4.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 125.55B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 67.78B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 36.24B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.99B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.77B 3.81B -644.79M -669.77M -6.24

Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2019-05-30 Eingeleitet H.C. Wainwright Buy
2018-04-10 Herabstufung Stifel Buy → Hold
2018-03-08 Eingeleitet ROTH Capital Buy
2018-02-08 Eingeleitet Northland Capital Outperform
2016-09-26 Eingeleitet H.C. Wainwright Buy
2015-09-04 Eingeleitet Canaccord Genuity Buy
2015-08-24 Eingeleitet Piper Jaffray Overweight
2015-08-24 Eingeleitet Stifel Buy
Alle ansehen

Vtv Therapeutics Inc Aktie (VTVT) Neueste Nachrichten

pulisher
Mar 27, 2025

vTv Therapeutics (NASDAQ:VTVT) Now Covered by StockNews.com - Defense World

Mar 27, 2025
pulisher
Mar 25, 2025

(VTVT) Trading Signals - Stock Traders Daily

Mar 25, 2025
pulisher
Mar 21, 2025

vTv Therapeutics Inc Reports Q4 2024 EPS of -$0.55, Beating Esti - GuruFocus.com

Mar 21, 2025
pulisher
Mar 21, 2025

vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update - GlobeNewswire

Mar 21, 2025
pulisher
Mar 21, 2025

The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics - Yahoo Finance

Mar 21, 2025
pulisher
Mar 20, 2025

VTv Therapeutics: Q4 Earnings Snapshot - CTPost

Mar 20, 2025
pulisher
Mar 20, 2025

VTv Therapeutics: Q4 Earnings Snapshot -March 20, 2025 at 06:02 pm EDT - Marketscreener.com

Mar 20, 2025
pulisher
Mar 20, 2025

vTv Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

FDA Greenlights vTv Diabetes Drug Trial as Cash Reserves Triple to $36.7M - StockTitan

Mar 20, 2025
pulisher
Mar 20, 2025

vTv Therapeutics Inc. (VTVT) reports earnings - Quartz

Mar 20, 2025
pulisher
Mar 20, 2025

Why Celsius Holdings Stock Popped This Week - The Globe and Mail

Mar 20, 2025
pulisher
Mar 20, 2025

Biotech Stock Roundup: Patient Death Hits SRPT, INCY Study Data & More - Zacks Investment Research

Mar 20, 2025
pulisher
Mar 20, 2025

Short Interest in vTv Therapeutics Inc. (NASDAQ:VTVT) Decreases By 13.6% - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Mar 19, 2025
pulisher
Mar 19, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Mar 19, 2025
pulisher
Mar 19, 2025

StockNews.com Begins Coverage on vTv Therapeutics (NASDAQ:VTVT) - Defense World

Mar 19, 2025
pulisher
Mar 17, 2025

vTv Therapeutics Soars 43% as FDA Lifts Clinical Hold on Diabetes Drug Trial - GuruFocus.com

Mar 17, 2025
pulisher
Mar 17, 2025

Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup - MarketScreener

Mar 17, 2025
pulisher
Mar 17, 2025

Sector Update: Health Care Stocks Rise Late Afternoon - TradingView

Mar 17, 2025
pulisher
Mar 17, 2025

Sector Update: Health Care -March 17, 2025 at 03:39 pm EDT - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

FDA Lifts Clinical Hold On vTv Therapeutics' Phase 3 Diabetes Trial, Stock Surges - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

FDA Lifts Clinical Hold, vTv Therapeutics (VTVT) Stock Surges - Stocks Telegraph

Mar 17, 2025
pulisher
Mar 17, 2025

vTv Therapeutics up after FDA lifts clinical hold on its oral diabetes treatment study - Seeking Alpha

Mar 17, 2025
pulisher
Mar 17, 2025

vTv Therapeutics resumes phase 3 diabetes trial By Investing.com - Investing.com Australia

Mar 17, 2025
pulisher
Mar 17, 2025

VTv Therapeutics Says FDA Lifted Clinical Hold On Cadisegliatin Program For Diabetes - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

vTv Therapeutics stock surges on FDA update By Investing.com - Investing.com Canada

Mar 17, 2025
pulisher
Mar 17, 2025

Vtv Therapeutics Says FDA Lifts Clinical Hold on Cadisegliatin Program for Diabetes; Shares Up Pre-Bell - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

vTv Therapeutics stock surges on FDA update - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

vTv Therapeutics resumes phase 3 diabetes trial - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

vTv Therapeutics Announces Resumption of CATT1 Phase 3 Trial for Cadisegliatin as Potential First Oral Adjunct Therapy for Type 1 Diabetes - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

vTv Therapeutics Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes - The Manila Times

Mar 17, 2025
pulisher
Mar 17, 2025

FDA Green Light: vTv's Revolutionary Oral Diabetes Drug Back on Track with Faster Timeline - StockTitan

Mar 17, 2025
pulisher
Mar 12, 2025

3 Quality Compounders on Our Buy List - The Globe and Mail

Mar 12, 2025
pulisher
Mar 10, 2025

vTv Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:VTVT - Benzinga

Mar 10, 2025
pulisher
Mar 07, 2025

vTv Therapeutics Inc expected to post a loss of 87 cents a shareEarnings Preview - TradingView

Mar 07, 2025
pulisher
Mar 05, 2025

vTv Therapeutics (VTVT) Projected to Post Quarterly Earnings on Tuesday - Defense World

Mar 05, 2025
pulisher
Mar 03, 2025

Long Term Trading Analysis for (VTVT) - Stock Traders Daily

Mar 03, 2025
pulisher
Feb 28, 2025

vTv Therapeutics CFO to Resign in March By Investing.com - Investing.com Canada

Feb 28, 2025
pulisher
Feb 27, 2025

vTv Therapeutics CFO to Resign in March - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

vTv Therapeutics CFO Steven Tuch to Resign - TipRanks

Feb 27, 2025
pulisher
Feb 23, 2025

vTv Therapeutics (NASDAQ:VTVT) Coverage Initiated at StockNews.com - Defense World

Feb 23, 2025

Finanzdaten der Vtv Therapeutics Inc-Aktie (VTVT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Kapitalisierung:     |  Volumen (24h):